Sonic Healthcare Limited
SHL.AX

$8.67 B
Marketcap
$18.06
Share price
Country
$-0.09
Change (1 day)
$21.28
Year High
$15.41
Year Low

Sonic Healthcare Limited offers medical diagnostic services to medical practitioners, hospitals, community health services, and their collective patients. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging, computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry. It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, after-hours general practice services, general practice IT solutions, and community-based healthcare services. The company operates in Australia, the United Kingdom, Ireland, the United States, Germany, Switzerland, New Zealand, Belgium, and internationally. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

marketcap

P/B ratio for Sonic Healthcare Limited (SHL.AX)

P/B ratio as of 2024: 1.54

According to Sonic Healthcare Limited's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 1.54. At the end of 2023 the company had a P/B ratio of 2.16.

P/B ratio history for Sonic Healthcare Limited from 1989 to 2024

P/B ratio at the end of each year

Year P/B ratio
2024 1.54
2023 2.16
2022 2.17
2021 2.87
2020 2.59
2019 2.25
2018 2.48
2017 2.64
2016 2.41
2015 2.62
2014 2.25
2013 1.98
2012 1.91
2011 1.99
2010 1.58
2009 1.78
2008 2.44
2007 3.15
2006 3.18
2005 3.86
2004 2.82
2003 2.03
2002 1.42
2001 2.62
2000 3.70
1999 9.12
1998 4.65
1997 3.74
1996 2.71
1995 2.22
1994 2.38
1993 4.33
1992 0.64
1991 5.78
1990 1.66
1989 3.62